Rare diseases
Investigational molecules
Locations
Back to Czechia394 clinical trials in Brno, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough
CzechiaCzechiaStudy on Izokibep for Patients with Non-infectious Uveitis
CzechiaStudy on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol
CzechiaStudy Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant
CzechiaStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
CzechiaStudy on Tralokinumab for Children Aged 6-11 with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
CzechiaStudy on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment
CzechiaStudy on Stopping Nilotinib, Imatinib, and Dasatinib in Patients with Chronic Myeloid Leukemia in Deep Remission
CzechiaStudy on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
CzechiaStudy of belantamab mafodotin, bortezomib and dexamethasone combination in adults with relapsed or refractory multiple myeloma who received at least one prior therapy
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for leukemia, prostate cancer, and gastric cancer.
Studies evaluating novel therapeutic combinations and targeted treatments for various cancer types.
Research focused on treating inflammatory disorders and autoimmune conditions, with particular emphasis on innovative therapies.
Evaluating new biological treatments and their long-term effectiveness in managing chronic conditions.
Studies addressing respiratory diseases and heart conditions, focusing on prevention and treatment strategies.
Testing innovative approaches to improve patient outcomes in respiratory and cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
